FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Marie Saint-Remy

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Mouse

Physiology

Co-author Network

Publications

TOP 3
Krisztina Szalai; Luc Vander Elst; Julia Wallmann; Tamara Kopp; Anna Lukschal; Isabella Pali-Schöll; Jean-Marie Saint-Remy; Philipp Starkl; Caroline Stremnitzer; Erika Jensen-Jarolim
Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice.
Manuela Rinaldi; Jean-Marie Saint-Remy; Renaud Lavend'homme; An Lehouck; Vincent Carlier; Marc Decramer; Ghislaine Gayan-Ramirez; Nele Heulens; Wim Janssens
Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease.
Vincent A Carlier; Marc Jacquemin; Wim Janssens; Luc VanderElst; Jean-Marie Saint-Remy
Increased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Marie Saint-Remy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Krisztina Szalai; Luc Vander Elst; Julia Wallmann; Tamara Kopp; Anna Lukschal; Isabella Pali-Schöll; Jean-Marie Saint-Remy; Philipp Starkl; Caroline Stremnitzer; Erika Jensen-Jarolim
Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice.
Experimental dermatology 2012;21(11):842-6.
2012: Manuela Rinaldi; Jean-Marie Saint-Remy; Renaud Lavend'homme; An Lehouck; Vincent Carlier; Marc Decramer; Ghislaine Gayan-Ramirez; Nele Heulens; Wim Janssens
Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease.
Thorax 2012;67(8):694-700.
2012: Vincent A Carlier; Marc Jacquemin; Wim Janssens; Luc VanderElst; Jean-Marie Saint-Remy
Increased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors.
PloS one 2012;7(10):e45366.
2011: B Pautard; Kathelijne Peerlinck; Jean-Marie Saint-Remy; Roseline d'Oiron; Renaud Lavend'homme; V Li Thiao Te; Marc Jacquemin
Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII-specific T cells.
Journal of thrombosis and haemostasis : JTH 2011;9(6):1163-70.
2011: Roxana R Ahangarani; Wim Janssens; Vincent Carlier; Luc VanderElst; Thierry VandenDriessche; Marinee Chuah; Marc Jacquemin; Jean-Marie Saint-Remy
Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(4):711-22.
2010: J D Dimitrov; Lubka T Roumenina; J-L Plantier; S Andre; D Saboulard; Y Meslier; C Planchais; Marc Jacquemin; Jean-Marie Saint-Remy; Boris P Atanasov; Srini V Kaveri; Sébastien Lacroix-Desmazes
A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF-binding site distant from its epitope.
Journal of thrombosis and haemostasis : JTH 2010;8(7):1524-31.
2010: Tina Shahani; Renaud Lavend'homme; Aernout Luttun; Jean-Marie Saint-Remy; Kathelijne Peerlinck; Marc Jacquemin
Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool.
Blood 2010;115(23):4902-9.
2010: Peter Verhamme; Steve Pakola; Thomas J Jensen; Kristina Berggren; Elisabeth Sonesson; Jean-Marie Saint-Remy; Torben Balchen; Ann Belmans; Geraldine Cahillane; Jean Marie Stassen; Kathelijne Peerlinck; Steven Glazer; Marc Jacquemin
Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.
Clinical therapeutics 2010;32(6):1205-20.
2009: Roxana Roohi Ahangarani; Wim Janssens; Luc VanderElst; Vincent Carlier; Thierry VandenDriessche; Marinee Chuah; Birgit Weynand; Jeroen A J Vanoirbeek; Marc Jacquemin; Jean-Marie Saint-Remy
In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(12):8232-43.
2009: Marc Jacquemin; Jean Marie Stassen; Jean-Marie Saint-Remy; Peter Verhamme; Renaud Lavend'homme; Luc VanderElst; M Meiring; H Pieters; S Lamprecht; J Roodt; P Badenhorst
A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons.
Journal of thrombosis and haemostasis : JTH 2009;7(3):429-37.
2009: Sebastian Knör; Burkhardt Laufer; Alexey Khrenov; Abdellah Benhida; Sabrina C Grailly; Nathalie Beaufort; Viktor Magdolen; Charlotte A E Hauser; Evgueni L Saenko; Jean-Marie Saint-Remy; Horst Kessler
Development of a small molecule peptidomimetic affinity ligand for efficient purification of the large protein factor VIII.
Advances in experimental medicine and biology 2009;611():151-2.
2008: Jean-Marie Saint-Remy
How to get rid of inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 3():33-5.
2008: Sebastian Knör; Alexey V Khrenov; B Laufer; Abdellah Benhida; Sabrina Grailly; R Schwaab; J Oldenburg; Nathalie Beaufort; Viktor Magdolen; Jean-Marie Saint-Remy; Evgueni L Saenko; Charlotte A E Hauser; Horst Kessler
Efficient factor VIII affinity purification using a small synthetic ligand.
Journal of thrombosis and haemostasis : JTH 2008;6(3):470-7.
2008: Krisztina Szalai; Jan Fuhrmann; Tea Pavkov; Michael Scheidl; Julia Wallmann; Kira H Brämswig; Susanne Vrtala; Otto Scheiner; Walter Keller; Jean-Marie Saint-Remy; Dirk Neumann; Isabella Pali-Schöll; Erika Jensen-Jarolim
Mimotopes identify conformational B-cell epitopes on the two major house dust mite allergens Der p 1 and Der p 2.
Molecular immunology 2008;45(5):1308-17.
2008: Suryasarathi Dasgupta; Ana-Maria Navarrete; Sébastien André; Bharath Wootla; Sandrine Delignat; Yohann Repesse; Jagadeesh Bayry; Antonino Nicoletti; Evgueni L Saenko; Roseline d'Oiron; Marc Jacquemin; Jean-Marie Saint-Remy; Srini V Kaveri; Sébastien Lacroix-Desmazes
Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation.
Haematologica 2008;93(1):83-9.
2007: Suryasarathi Dasgupta; Ana-Maria Navarrete; Jagadeesh Bayry; Sandrine Delignat; Bharath Wootla; Sébastien André; Olivier Christophe; Michelina Nascimbeni; Marc Jacquemin; Luisa Martinez-Pomares; Teunis B H Geijtenbeek; Arnaud Moris; Jean-Marie Saint-Remy; Michel D Kazatchkine; Srini V Kaveri; Sébastien Lacroix-Desmazes
A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):8965-70.
2007: Suryasarathi Dasgupta; Yohann Repesse; Jagadeesh Bayry; Ana-Maria Navarrete; Bharath Wootla; Sandrine Delignat; Theano Irinopoulou; Caroline Kamaté; Jean-Marie Saint-Remy; Marc Jacquemin; Peter J Lenting; Annie Borel-Derlon; Srini V Kaveri; Sébastien Lacroix-Desmazes
VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.
Blood 2007;109(2):610-2.
2006: Marc Jacquemin; Arne P Neyrinck; Maria Iris Hermanns; Renaud Lavend'homme; Filip R Rega; Jean-Marie Saint-Remy; Kathelijne Peerlinck; Dirk E M Van Raemdonck; Charles James Kirkpatrick
FVIII production by human lung microvascular endothelial cells.
Blood 2006;108(2):515-7.
2006: Marc Jacquemin; Catherine M Radcliffe; Renaud Lavend'homme; Mark R Wormald; Luc VanderElst; G Wallays; J Dewaele; Désiré Collen; Jos Vermylen; Raymond A Dwek; Jean-Marie Saint-Remy; Pauline M Rudd; Mieke Dewerchin
Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody.
Journal of thrombosis and haemostasis : JTH 2006;4(5):1047-55.
2006: Sonia de Halleux; Enrico A Stura; Luc VanderElst; Vincent Carlier; Marc Jacquemin; Jean-Marie Saint-Remy
Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen.
The Journal of allergy and clinical immunology 2006;117(3):571-6.
2004: Jean-Marie Saint-Remy; S Lacroix-Desmazes; J Oldenburg
Inhibitors in haemophilia: pathophysiology.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10 Suppl 4():146-51.
2004: Marc Jacquemin; Jean-Marie Saint-Remy
The use of antibodies to coagulation factors for anticoagulant therapy.
Current medicinal chemistry 2004;11(17):2291-6.
2004: Marc Jacquemin; Jean-Marie Saint-Remy
Factor VIII alloantibodies in hemophilia.
Current opinion in hematology 2004;11(3):146-50.
2004: Jean-Guy G Gilles; Sabrina Grailly; Marc De Maeyer; Marc Jacquemin; Luc VanderElst; Jean-Marie Saint-Remy
In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody.
Blood 2004;103(7):2617-23.
2004: Mieke Dewerchin; L Van der Elst; I Singh; Sabrina Grailly; Jean-Marie Saint-Remy; Désiré Collen; Marc Jacquemin
Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice.
Journal of thrombosis and haemostasis : JTH 2004;2(1):77-84.
2004: Roseline d'Oiron; Jean-Maurice Lavergne; Renaud Lavend'homme; Abdellah Benhida; Jean Claude Bordet; Claude Negrier; Kathelijne Peerlinck; Jos Vermylen; Jean-Marie Saint-Remy; Marc Jacquemin
Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development.
Blood 2004;103(1):155-7.
2003: Wim Janssens; Vincent Carlier; Bo Wu; Luc VanderElst; Marc Jacquemin; Jean-Marie Saint-Remy
CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(9):4604-12.
2003: Sanjeev Raut; Sylvie Villard; Sabrina Grailly; Jean-Guy G Gilles; Claude Granier; Jean-Marie Saint-Remy; Trevor Barrowcliffe
Anti-heavy-chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor.
Thrombosis and haemostasis 2003;90(3):385-97.
2003: Sylvie Villard; Sébastien Lacroix-Desmazes; Thomas Kieber-Emmons; Dominique Piquer; Sabrina Grailly; Abdellah Benhida; Srini V Kaveri; Jean-Marie Saint-Remy; Claude Granier
Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor.
Blood 2003;102(3):949-52.
2003: Marc Jacquemin; Marc De Maeyer; Roseline d'Oiron; Renaud Lavend'homme; Kathelijne Peerlinck; Jean-Marie Saint-Remy
Molecular mechanisms of mild and moderate hemophilia A.
Journal of thrombosis and haemostasis : JTH 2003;1(3):456-63.
2003: Marc Jacquemin; Valérie Vantomme; Cécile Buhot; Renaud Lavend'homme; Wivine Burny; Nathalie Demotte; Pascal Chaux; Kathelijne Peerlinck; Jos Vermylen; Bernard Maillere; Pierre van der Bruggen; Jean-Marie Saint-Remy
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
Blood 2003;101(4):1351-8.
2003: Wim Janssens; Marinee K L Chuah; Luigi Naldini; Antonia Follenzi; Désiré Collen; Jean-Marie Saint-Remy; Thierry VandenDriessche
Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent.
Human gene therapy 2003;14(3):263-76.
2002: Ade Kallas; Margus Pooga; Abdellah Benhida; Marc Jacquemin; Jean-Marie Saint-Remy
Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor.
Thrombosis research 2002;107(6):291-302.
2002: Bo Wu; Luc Vander Elst; Vincent Carlier; Marc Jacquemin; Jean-Marie Saint-Remy
The Dermatophagoides pteronyssinus group 2 allergen contains a universally immunogenic T cell epitope.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2430-5.
2002: Marlene Behrmann; John Pasi; Jean-Marie Saint-Remy; Ronald Kotitschke; Michael Kloft
Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
Thrombosis and haemostasis 2002;88(2):221-9.
2002: Sylvie Villard; Dominique Piquer; Sanjeev Raut; Jean-Paul Léonetti; Jean-Marie Saint-Remy; Claude Granier
Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8.
The Journal of biological chemistry 2002;277(30):27232-9.
2002: Jean-Marie Saint-Remy
Immunology of factor VIII inhibitors.
Seminars in thrombosis and hemostasis 2002;28(3):265-8.
2002: Inderjit Singh; Alberto Smith; Beatrijs Vanzieleghem; Désiré Collen; Kevin Burnand; Jean-Marie Saint-Remy; Marc Jacquemin
Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model.
Blood 2002;99(9):3235-40.
2002: Carmen García-Martín; Marinee K L Chuah; An Van Damme; Kelly E Robinson; Beatrijs Vanzieleghem; Jean-Marie Saint-Remy; Dominique Gallardo; Frederick A Ofosu; Thierry VandenDriessche; Gonzalo Hortelano
Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A.
The journal of gene medicine 2002;4(2):215-23.
2002: Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Namita Misra; Michael P Horn; Sylvie Villard; Anastas Pashov; Natalie Stieltjes; Roseline d'Oiron; Jean-Marie Saint-Remy; Johan Hoebeke; Michel D Kazatchkine; Joseph Reinbolt; Dipika Mohanty; Srini V Kaveri
The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
The New England journal of medicine 2002;346(9):662-7.
2001: P Clint Spiegel; Marc Jacquemin; Jean-Marie Saint-Remy; Barry L Stoddard; Kathleen P Pratt
Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII.
Blood 2001;98(1):13-9.
2001: Marc Jacquemin; Beatrijs Vanzieleghem; Jean-Marie Saint-Remy
Mechanisms of B-cell tolerance.
Advances in experimental medicine and biology 2001;489():99-108.
2001: Rachel T Barrow; John Francis Healey; Marc Jacquemin; Jean-Marie Saint-Remy; Pete Lollar
Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
Blood 2001;97(1):169-74.
2000: Jean-Marie Saint-Remy
Hemophilia factor VIII therapy. B- and T-cell tolerance: from basic concepts to clinical practice.
Haematologica 2000;85(10 Suppl):93-6.
2000: Jean-Guy G Gilles; Beatrijs Vanzieleghem; Jean-Marie Saint-Remy
Animal models to explore mechanisms of tolerance induction to FVIII: SCID mice and SCID-FVIII-KO mice.
Haematologica 2000;85(10 Suppl):103-6; discussion 106-7.
2000: Marc Jacquemin; Renaud Lavend'homme; Abdellah Benhida; Beatrijs Vanzieleghem; Roseline d'Oiron; Jean-Maurice Lavergne; H H Brackmann; R Schwaab; Thierry VandenDriessche; Marinee K L Chuah; Marc F Hoylaerts; Jean-Guy G Gilles; Kathelijne Peerlinck; Jos Vermylen; Jean-Marie Saint-Remy
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.
Blood 2000;96(3):958-65.
2000: Beatrijs Vanzieleghem; Jean-Guy G Gilles; BG Desqueper; Jos Vermylen; Jean-Marie Saint-Remy
Humanized severe combined immunodeficient mice as a potential model for the study of tolerance to factor VIII.
Thrombosis and haemostasis 2000;83(6):833-9.
2000: Sébastien Lacroix-Desmazes; A Moreau; Anastas Pashov; Dorothea Stahl; Jean-Marie Saint-Remy; Srini V Kaveri; Michel D Kazatchkine
Natural antibodies to factor VIII.
Seminars in thrombosis and hemostasis 2000;26(2):157-65.
2000: Jean-Guy G Gilles; Beatrijs Vanzieleghem; Jean-Marie Saint-Remy
Factor VIII Inhibitors. Natural autoantibodies and anti-idiotypes.
Seminars in thrombosis and hemostasis 2000;26(2):151-5.
2000: Marc Jacquemin; Abdellah Benhida; Kathelijne Peerlinck; BG Desqueper; Luce Vander Elst; Renaud Lavend'homme; Roseline d'Oiron; R Schwaab; M Bakkus; K Thielemans; Jean-Guy G Gilles; Jos Vermylen; Jean-Marie Saint-Remy
A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor.
Blood 2000;95(1):156-63.
2000: Bo Wu; G Toussaint; Luce Vander Elst; C Granier; Marc Jacquemin; Jean-Marie Saint-Remy
Major T cell epitope-containing peptides can elicit strong antibody responses.
European journal of immunology 2000;30(1):291-9.
1999: Jean-Guy G Gilles; Renaud Lavend'homme; Kathelijne Peerlinck; Marc Jacquemin; Marc F Hoylaerts; Sylvie Jorieux; Claudine Mazurier; Jos Vermylen; Jean-Marie Saint-Remy
Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
Thrombosis and haemostasis 1999;82(1):40-5.
1999: Kathelijne Peerlinck; Marc Jacquemin; Jef Arnout; Marc F Hoylaerts; Jean-Guy G Gilles; Renaud Lavend'homme; K M Johnson; Kathleen Freson; Dorothea Scandella; Jean-Marie Saint-Remy; Jos Vermylen
Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A.
Blood 1999;93(7):2267-73.
1999: Jean-Marie Saint-Remy; Marc Jacquemin; Jean-Guy G Gilles
Anti-idiotypic antibodies: from regulation to therapy of factor VIII inhibitors.
Vox sanguinis 1999;77 Suppl 1():21-4.
1998: Marc Jacquemin; BG Desqueper; Abdellah Benhida; Luce Vander Elst; Marc F Hoylaerts; M Bakkus; K Thielemans; Jef Arnout; Kathelijne Peerlinck; Jean-Guy G Gilles; Jos Vermylen; Jean-Marie Saint-Remy
Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor.
Blood 1998;92(2):496-506.
1998: Marc Jacquemin; Jean-Marie Saint-Remy
Factor VIII immunogenicity.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):552-7.
1997: Jean-Guy G Gilles; Marc Jacquemin; Jean-Marie Saint-Remy
Factor VIII inhibitors.
Thrombosis and haemostasis 1997;78(1):641-6.
1997: Jean-Guy G Gilles; Kathelijne Peerlinck; Jef Arnout; Jos Vermylen; Jean-Marie Saint-Remy
Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
Thrombosis and haemostasis 1997;77(5):938-43.
1997: Jean-Marie Saint-Remy
Epitope mapping: a new method for biological evaluation and immunotoxicology.
Toxicology 1997;119(1):77-81.
1997: Jean-Guy G Gilles; Mario Di Giambattista; Ruth Laub; Jean-Marie Saint-Remy
Heating lyophilised factor VIII does not alter its recognition by specific antibodies.
Vox sanguinis 1997;73(1):16-23.
1997: Wivine Burny; P Lebrun; J P Cosyns; Jean-Marie Saint-Remy
Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRLlpr mice.
Lupus 1997;6(1):4-17.
1997: Kathelijne Peerlinck; Jef Arnout; Mario Di Giambattista; Jean-Guy G Gilles; Ruth Laub; Marc Jacquemin; Jean-Marie Saint-Remy; Jos Vermylen
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
Thrombosis and haemostasis 1997;77(1):80-6.
1996: Jean-Guy G Gilles; B Desqueper; H Lenk; Jos Vermylen; Jean-Marie Saint-Remy
Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
The Journal of clinical investigation 1996;97(6):1382-8.
1996: Jean-Marie Saint-Remy; Jean-Guy G Gilles
Variations in antigenicity of factor VIII concentrates: preclinical evaluation.
Vox sanguinis 1996;70 Suppl 1():15-8.
1995: Jean-Guy G Gilles; Jean-Marie Saint-Remy
Strategy for pre-clinical evaluation of factor VIII concentrates.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6 Suppl 2():S58-61.
1995: Marc Jacquemin; Jean-Marie Saint-Remy
Epitope-specific down-regulation of anti-allergen antibodies following injection of allergen-antibody complexes in hypersensitive patients.
International archives of allergy and immunology 1995;107(1-3):313-5.
1995: B P Leroy; Marc Jacquemin; J M Lachapelle; Jean-Marie Saint-Remy
Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab')2 fragments of specific antibodies.
The British journal of dermatology 1995;132(4):599-603.
1995: Marc Jacquemin; Jean-Marie Saint-Remy
Specific down-regulation of anti-allergen IgE and IgG antibodies in humans associated with injections of allergen-specific antibody complexes.
Therapeutic immunology 1995;2(1):41-52.
1994: Jean-Marie Saint-Remy; J J Machiels
Allergen-antibody complexes in the treatment of Dermatophagoides pteronyssinus hypersensitivity diseases.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1994;24(12):1091-3.
1994: Jean-Guy G Gilles; Jean-Marie Saint-Remy
Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
The Journal of clinical investigation 1994;94(4):1496-505.
1994: P Lebrun; Wivine Burny; J P Cosyns; Jean-Marie Saint-Remy
Injections of complexes made of dsDNA and specific polyclonal antibodies extend MRL lpr mouse survival: a pilot study.
Lupus 1994;3(1):47-53.
1994: Jean-Marie Saint-Remy
Novel approaches in immunotherapy.
Clinical reviews in allergy 1994;12(1):23-42.
1993: Jean-Guy G Gilles; Jef Arnout; Jos Vermylen; Jean-Marie Saint-Remy
Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction.
Blood 1993;82(8):2452-61.
1993: J J Machiels; P M Lebrun; Marc Jacquemin; Jean-Marie Saint-Remy
Significant reduction of nonspecific bronchial reactivity in patients with Dermatophagoides pteronyssinus-sensitive allergic asthma under therapy with allergen-antibody complexes.
The American review of respiratory disease 1993;147(6 Pt 1):1407-12.
1993: Kathelijne Peerlinck; Jef Arnout; Jean-Guy G Gilles; Jean-Marie Saint-Remy; Jos Vermylen
A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
Thrombosis and haemostasis 1993;69(2):115-8.
1993: B P Leroy; G Boden; J M Lachapelle; Marc Jacquemin; Jean-Marie Saint-Remy
A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study.
Journal of the American Academy of Dermatology 1993;28(2 Pt 1):232-9.
1993: B Leroy; J M Lachapelle; Marc Jacquemin; Jean-Marie Saint-Remy
Immunotherapy of atopic dermatitis by injections of antigen-antibody complexes.
Dermatology (Basel, Switzerland) 1993;186(4):276-7.
1992: B P Leroy; J M Lachapelle; Marc Jacquemin; Jean-Marie Saint-Remy
Treatment of atopic dermatitis by allergen-antibody complexes: long-term clinical results and evolution of IgE antibodies.
Dermatology (Basel, Switzerland) 1992;184(4):271-4.
1992: B P Leroy; G Boden; Marc Jacquemin; J M Lachapelle; Jean-Marie Saint-Remy
Allergen-antibody complexes in the treatment of atopic dermatitis: preliminary results of a double-blind placebo-controlled study.
Acta dermato-venereologica. Supplementum 1992;176():129-31.
1991: J J Machiels; M A Somville; Marc Jacquemin; Jean-Marie Saint-Remy
Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy.
Allergy 1991;46(5):335-48.
1991: B P Leroy; J M Lachapelle; M M Somville; Marc Jacquemin; Jean-Marie Saint-Remy
Injection of allergen-antibody complexes is an effective treatment of atopic dermatitis.
Dermatologica 1991;182(2):98-106.
1990: J J Machiels; M Buche; M A Somville; Marc Jacquemin; Jean-Marie Saint-Remy
Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1990;20(6):653-60.
1990: Marc Jacquemin; J J Machiels; P M Lebrun; Jean-Marie Saint-Remy
Successful treatment of atopic dermatitis with complexes of allergen and specific antibodies.
Lancet 1990;335(8703):1468-9.
1990: J J Machiels; M A Somville; P M Lebrun; S J Lebecque; Marc Jacquemin; Jean-Marie Saint-Remy
Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.
The Journal of clinical investigation 1990;85(4):1024-35.
1989: M A Somville; J Machiels; Jean-Guy G Gilles; Jean-Marie Saint-Remy
Seasonal variation in specific IgE antibodies of grass-pollen hypersensitive patients depends on the steady state IgE concentration and is not related to clinical symptoms.
The Journal of allergy and clinical immunology 1989;83(2 Pt 1):486-94.
1989: Marc Jacquemin; Jean-Marie Saint-Remy
Idiotopes carried by antiallergen antibodies.
Methods in enzymology 1989;178():150-63.
1988: Jean-Marie Saint-Remy; P M Lebrun; S J Lebecque; P L Masson
Human immune response to allergens of house dust mite, Dermatophagoides pteronyssinus. Isotypic analysis of antibodies in atopic and non-atopic subjects.
Allergy 1988;43(5):338-47.
1988: Jean-Marie Saint-Remy; S J Lebecque; P M Lebrun; Marc Jacquemin
Human immune response to allergens of house dust mite, Dermatophagoides pteronyssinus. V. Auto-anti-idiotypic antibody characterization and cross-reactivity.
European journal of immunology 1988;18(7):1009-14.
1988: Jean-Guy G Gilles; J C Mareschal; Jean-Marie Saint-Remy
Latex allergosorbent test (LAST): a new immunoassay for specific IgE with latex particles.
The Journal of allergy and clinical immunology 1988;82(1):35-9.
1988: Jean-Marie Saint-Remy; S J Lebecque; P M Lebrun
Human immune response to allergens of house dust mite, Dermatophagoides pteronyssinus. III. Cross-reactivity of bystander idiotopes on allergen-specific IgE antibodies.
European journal of immunology 1988;18(1):77-81.
1988: Jean-Marie Saint-Remy; S J Lebecque; P M Lebrun; Marc Jacquemin
Human immune response to allergens of house dust mite, Dermatophagoides pteronyssinus. IV. Occurrence of natural autologous anti-idiotypic antibodies.
European journal of immunology 1988;18(1):83-7.
1986: Jean-Marie Saint-Remy; P M Lebrun; S J Lebecque; P L Masson
The human immune response against major allergens from house dust mite, Dermatophagoides pteronyssinus. II. Idiotypic cross-reactions of allergen-specific antibodies.
European journal of immunology 1986;16(5):575-80.